Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Clopidogrel Discontinuation Before CABG Surgery

Timing of Clopidogrel Discontinuation

  • For elective CABG surgery, the American College of Cardiology recommends discontinuing clopidogrel at least 5 days prior to surgery to limit bleeding complications and blood transfusion requirements 1, 2, 3
  • Discontinue clopidogrel at least 5 days before elective surgery to minimize bleeding risk and transfusion requirements, as suggested by the American College of Cardiology 2, 4, 3
  • For urgent CABG, discontinue clopidogrel for at least 24 hours before surgery to reduce major bleeding complications, according to the American Heart Association 1, 2, 3
  • In urgent cases, proceeding with CABG after at least 24 hours of clopidogrel discontinuation is reasonable, though it carries increased bleeding risk, as stated by the American College of Cardiology 1, 2
  • Blood transfusion requirements are likely to be higher when CABG is performed 1-4 days after clopidogrel discontinuation, as reported by the American College of Cardiology 3, 5

Comparison with Other Antiplatelet Agents

  • Prasugrel requires a longer discontinuation period of at least 7 days before elective CABG, as recommended by the American College of Cardiology 1, 4
  • Ticagrelor should be discontinued for at least 5 days before elective CABG, similar to clopidogrel, according to the American Heart Association 1, 4
  • For urgent CABG, both ticagrelor and clopidogrel should be discontinued for at least 24 hours, as suggested by the American College of Cardiology 1, 2

Resumption of Antiplatelet Therapy

  • Resume clopidogrel as soon as hemostasis is achieved, typically within 24 hours after CABG, as recommended by the American College of Chest Physicians 4
  • Early resumption of antiplatelet therapy is important to prevent graft occlusion and adverse cardiovascular events, according to the American College of Chest Physicians 4

Clinical Considerations

  • For patients with high thrombotic risk, the decision to discontinue clopidogrel should balance bleeding risk against thrombotic risk, as stated by the American Heart Association 6

REFERENCES